A Potent Small Molecule Inhibitor of FLT3, PHI-101 Overcomes Resistance in Acute Myeloid Leukemia: Efficacy and PK/PD Profile in Phase 1 First in Human Study
Year: 2022
Type: article
Study design: Clinical Trial
Abstract: title: A Potent Small Molecule Inhibitor of FLT3, PHI-101 Overcomes Resistance in Acute Myeloid Leukemia: Efficacy and PK/PD Profile in Phase 1 First in Human Study, doi: 10.1182/blood-2022-165000, category: Article
Source: Blood
Institutions: Seoul National University, Seoul National University Hospital, Asan Medical Center, Seoul National University Bundang Hospital, University of Ulsan, Samsung Medical Center, Sungkyunkwan University, Yonsei University, Severance Hospital, Pusan National University Hospital, Johns Hopkins University, Johns Hopkins Medicine
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4310106491